Presentation is loading. Please wait.

Presentation is loading. Please wait.

Quality Metrics In CRRT Dr Prabh Nayak Lead Consultant for CRRT, Liver, Kidney & Small Bowel Transplant Birmingham Children’s Hospital, UK.

Similar presentations


Presentation on theme: "Quality Metrics In CRRT Dr Prabh Nayak Lead Consultant for CRRT, Liver, Kidney & Small Bowel Transplant Birmingham Children’s Hospital, UK."— Presentation transcript:

1 Quality Metrics In CRRT Dr Prabh Nayak Lead Consultant for CRRT, Liver, Kidney & Small Bowel Transplant Birmingham Children’s Hospital, UK

2 Where are we?

3 BCH 31 bedded PICU with approx 1500 admissions annually Children’s hospital with all major subspecialities represented (renal, liver, cardiac surgery, ECLS, haem-onc, neurosurgery, trauma, burns, metabolic, transplant) CRRT service model: PIC driven and PIC delivered 50-60 patients receive CVVH/CVVHDF per year

4 Critically ill pts on CRRT have high mortality Death in CRRT pts CRRT pts Mortality % 2009154335 2010124030 2011153148 2012146023 2013246338 2014133735 2015 (Q1)71547 Grand Total10028935

5 Quality in CRRT To be able to deliver a consistent service with minimal deviation from the standard & minimise variation in practice with minimal complications. Standards & guidelines To the right patient At the right time In the right setting Using the right equipment By the right people Knowledge sharing & improvement

6 Quality Improvement Metrics Outcomes - Circuit life - Circuit downtime - Time to initiate in time-critical conditions (hyperammonaemia) - Ability to provide intra-operative CRRT cover Safety - Any human factors issues? Cost Improvement Process (Vascath, CVVH solutions) Morbidity and mortality case reviews; Audit against standards Service improvements Educational preparedness: Wet labs, simulation sessions

7 ‘Standardisation’ of timing of CRRT initiation possible?

8 Fluid Overload and outcomes Gillespie et al, Pediatr Nephrol (2004) 19:1394-1999 Kaplan-Meier survival estimates, by percentage fluid overload category

9

10 Randomised Evaluation of Normal vs Augmented Level (RENAL) therapy 1500 critically ill adults CVVHDF 25 ml/kg/hour 40 ml/kg/hour

11 Where speed of initiation is of the essence Change of provision of service Many of these patients retrieved from referring hospitals Pre-primed circuit Senior ready for Vascath insertion Small numbers but ticking time-bombs! Need to decrease the time delay between admission & filtration Hyperammonaemia Year Numbers 2010 5 20115 20125 20137 20143 20152 Grand Total27

12

13 Build a good ‘CRRT team’

14

15

16 Bridging The Gap: Improving Patient Safety Through Targeted In-Situ Simulation Training Nayak PP, Kidd N, Osborne-Ricketts B, Martin J, Heward Y Pediatric Critical Care Medicine: May 2014 - Volume 15 - Issue 4 (=proof of high quality care and excellent outcomes)

17 Bridging The Gap: Improving Patient Safety Through Targeted In-Situ Simulation Training Nayak PP, Kidd N, Osborne-Ricketts B, Martin J, Heward Y Pediatric Critical Care Medicine: May 2014 - Volume 15 - Issue 4 (=proof of high quality care and excellent outcomes)

18

19

20 Collect data, analyse and modify practice

21

22 CRRT Database @ BCH

23

24

25

26

27 PICANET (Paediatric Intensive Care Audit Network, UK) dataset collection from 2015

28

29

30 CRRT durations Median CRRT duration 90 hrs ( IQR 32 – 186 hrs) Mean 166:52:03 Minimum duration 1hr 40min Maximum duration 1975 hrs!

31 Anticoagulation in our program Heparin alone Year Numbers 2009 23 2010 26 2011 21 2012 48 2013 41 2014 26 2015 7 Grand Total 192 Prostacyclin alone4 Heparin + Prostacyclin Year Numbers 2009 3 2012 1 2013 7 2014 3 2015 1 Grand Total15

32 Prognostication & treatment decision Herpes Survivors (n=5) Non-Survivors (n=6) Initial presentation Non-specific illness (8) Clinical septicaemia (2) Clinical coagulopathy (3) 5/8(62%) 0/2 0/3 3/8 (38%) 2/2 (100%) 3/3 (100%) HSV 1 HSV 2 2 (40%) 3 (60%) 4 (66%) 2 (33%) Aciclovir (time commenced at referring hospital) ≤ 2days (5) > 2days (4) 3/5 (60%) 2/4 (50%) 2/5 (40%) 2/4 (50%) Inotropes (8)2/8 (25%)6/8 (75%) CVVH (7)1/7 (15%)6/7 (85%)

33

34 What does the future hold? Timing of initiation of CRRT & role of biomarkers? Drug PK studies on extracorporeal circuit Technological innovations in circuit sizes Subspecialised CRRT teams Shared learning from pooled data; multi-centre research

35 Thank you


Download ppt "Quality Metrics In CRRT Dr Prabh Nayak Lead Consultant for CRRT, Liver, Kidney & Small Bowel Transplant Birmingham Children’s Hospital, UK."

Similar presentations


Ads by Google